Brain anatomy and ageing in non-demented adults with down's syndrome: An in vivo MRI study

Psychological Medicine

Volumn 40, Issue 4, 2010, Pages 611-619

  Beacher, F ^a   Daly, E ^a   Simmons, A ^a   Prasher, V ^b   Morris, R ^a   Robinson, C ^b   Lovestone, S ^a   Murphy, K ^a,c   Murphy, D G M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b Monyhull Hospital   (United Kingdom)

^c Department of General Practice   (Ireland)

Author keywords

Ageing; Alzheimer's disease; Dementia; Down's syndrome; Magnetic resonance imaging

Indexed keywords

ADULT; AGED; AGING; ARTICLE; BRAIN; COGNITIVE DEFECT; DOWN SYNDROME; FEMALE; HISTOLOGY; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY;

ADULT; AGED; AGING; BRAIN; COGNITION DISORDERS; DOWN SYNDROME; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 77952426708     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291709990985     Document Type: Article

References (33)

1. Aylward EH, Li Q, Habbak QR, Warren A, Pulsifer MB, Barta PE, Jerram M, Pearlson G (1997). Basal ganglia volume in adults with Down syndrome. Psychiatry Research 74, 73-82. (Pubitemid 27288516)
2. Aylward EH, Li Q, Honeycutt NA, Warren AC, Pulsifer MB, Barta PE, Chan MD, Smith PD, Jerram M, Pearlson GD (1999). MRI volumes of the hippocampus and amygdala in adults with Down's syndrome with and without dementia. American Journal of Psychiatry 156, 564-568.
3. Barta PE, Dhingra L, Royall R, Schwartz E (1997). Improving stereological estimates for the volume of structures identified in three-dimensional arrays of spatial data. Journal of Neuroscience Methods 75, 111-118.
4. 1H-MRS study. Archives of General Psychiatry 62, 1360-1365.
5. Blessed G, Black SE, Butler T, Kay DW (1991). The diagnosis of dementia in the elderly. A comparison of CAMCOG (the cognitive section of CAMDEX), the AGECAT program, DSM-III, the Mini-Mental State Examination and some short rating scales. British Journal of Psychiatry 159, 193-198.
6. Brooksbank BWL, Balazs R (1984). Superoxide dismutase, glutathione peroxidase and lipoperoxidation in Down's syndrome fetal brain. Brain Research 16, 37-44.
7. Capone T (2001). Down syndrome: advances in molecular biology and the neurosciences. Developmental and Behavioural Pediatrics 22, 40-59.
8. Dunn L, Whetton C, Burley J (1997). British Picture Vocabulary Scale, 2nd edn. NFER Nelson: Windsor.
9. Firbank MJ, Harrison RM, O'Brien JT (2002). A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Geriatric Cognitive Disorders 14, 64-76.
10. Hof PR, Bouras C, Perl DP, Sparks DL, Mehta N, Morrison JH (1995). Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Archives of Neurology 52, 379-391.
11. Holland AJ, Hon J, Huppert FA, Stevens F (2000). Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. Journal of Intellectual Disability Research 44, 138-146.
12. Hon J, Huppert FA, Holland AJ, Watson P (1999). Neuropsychological assessment of older adults with Down's syndrome: an epidemiological study using the Cambridge Cognitive Examination (CAMCOG). British Journal of Clinical Psychology 38, 155-165.
13. Huang W, Alexander GE, Daly EM, Shetty HU, Krasuski JS, Rapoport SI, Schapiro MB (1999). High brain myo-inositol levels in the predementia phase of Alzheimer's disease in adults with Down's syndrome: a 1H MRS study. American Journal of Psychiatry 156, 1879-1886.
14. Ianello RC, Crack PJ, de Haan JB, Kola I (1999). Oxidative stress and neural dysfunction in Down syndrome. Journal of Neural Transmission. Supplementum 57, 257-267.
15. Kesslak JP, Nagata SF, Lott I, Nalcioglu O (1994). MRI analysis of age-related changes in the brains of individuals with DS. Neurology 44, 1039-1045.
16. Krasuski JS, Alexander GE, Horwitz B, Rapoport SI, Schapiro MB (2002). Relation of medial temporal volumes to age and memory function in nondemented adults with Down's syndrome: implications for the prodromal phase of Alzheimer's disease. American Journal of Psychiatry 159, 74-81.
17. Lindeboom J, Weinstein H (2004). Neuropsychology of cognitive ageing, minimal cognitive impairment, Alzheimer's disease, and vascular cognitive impairment. European Journal of Pharmacology 490, 83-86.
18. Mann DM (1988). The pathological association between Down syndrome and Alzheimer disease. Mechanisms of Ageing and Development 43, 99-136.
19. Masliah E, Sisk A, Mallory M, Mucke L, Schenk D, Games D (1996). Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. Journal of Neuroscience 16, 5795-5811.
20. McLaurin J, Franklin T, Chakrabartty A, Fraser PE (1998). Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest. Journal of Molecular Biology 278, 183-194.
21. Murphy DG, DeCarli C, McIntosh AR, Daly E, Mentis MJ, Pietrini P, Szczepanik J, Schapiro MB, Grady CL, Horwitz B, Rapoport SI (1996). Sex differences in human brain morphometry and metabolism: an in vivo quantitative magnetic resonance imaging and positron emission tomography study on the effect of aging. Archives of General Psychiatry 53, 585-594.
22. Pinter JD, Brown WE, Eliez S, Schmitt JE, Capone GT, Reiss AL (2001a). Amygdala and hippocampal volumes in children with Down syndrome: a high-resolution MRI study. Neurology 56, 972-974.
23. Pinter JD, Eliez S, Schmitt JE, Capone GT, Reiss AL (2001b). Neuroanatomy of Down's syndrome: a high resolution MRI study. American Journal of Psychiatry 158, 1659-1665.
24. Prasher VP, Farrer MJ, Kessling AM, Fisher EM, West RJ, Barber PC, Butler AC (1998). Molecular mapping of Alzheimer-type dementia in Down's syndrome. Annals of Neurology 43, 380-383.
25. Raz N, Torres IJ, Briggs SD, Spencer WD, Thornton AE, Loken WJ, Gunning FM, McQuain JD, Driesen NR, Acker JD (1995). Selective neuroanatomical abnormalities in Down's syndrome and their cognitive correlates: evidence from MRI morphometry. Neurology 45, 356-366.
26. Resnick SM, Pham DL, Kraut MA, Zonderman AB, Davatzikos C (2003). Longitudinal magnetic resonance imaging studies of older adults: a shrinking brain. Journal of Neuroscience 23, 3295-3301.
27. Rondal JA, Comblain A (2002). Language in ageing persons with Down syndrome. Down's Syndrome: Research and Practice 8, 1-9.
28. Roth GM, Sun B, Greensite FS, Lott IT, Dietrich RB (1996). Premature aging in persons with Down syndrome: MR findings. American Journal of Neuroradiology 17, 1283-1289.
29. Roth M, Huppert FA, Mountjoy CQ, Tym E (1998). The Revised Cambridge Examination for Mental Disorders of the Elderly. Cambridge University Press: Cambridge.
30. Teipel SJ, Alexander GE, Schapiro MB, Möller HJ, Rapoport SI, Hampel H (2004). Age-related cortical grey matter reductions in non-demented Down's syndrome adults determined by MRI with voxel-based morphometry. Brain 127, 811-824.
31. Teipel SJ, Schapiro MB, Alexander GE, Krasuski JS, Horwitz B, Hoehne C, Möller HJ, Rapoport SI, Hampel H (2003). Relation of corpus callosum and hippocampal size to age in nondemented adults with Down's syndrome. American Journal of Psychiatry 160, 1870-1878.
32. Visser FE, Aldenkamp AP, van Huffelen AC, Kuilman M, Overweg J, van Wijk J (1997). Prospective study of the Alzheimer-type dementia in institutionalized individuals with Down syndrome. American Journal of Mental Retardation 101, 400-412
33. WHO (1992). The ICD-10 Classification of Mental and Behavioural Disorders. Clinical Descriptions and Diagnostic Guidelines. World Health Organization: Geneva.